Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

3.985 -0.015 (-0.38%)
Streaming Delayed Price Updated: 1:06 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atai Beckley N.V - Common Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
29 30 Next >
News headline image
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
The "Rags-To-Riches" Portfolio Update: Week Ending January 27 ↗
The Rags-to-Riches Portfolio tracks the performance of 14 cannabis, psychedelic and plant-based food stocks constituent . Here, performances last week and year-to-date. 
Via Talk Markets
News headline image
Top 3 Psychedelic Storylines To Watch In 2023 ↗
This article by James Hallifax was originally published on Microdose and appears here with permission. 
Via Benzinga
News headline image
Largest Psychedelic Stocks +1.2% This Week; Now +16.1% YTD ↗
We track the 6 largest psychedelic stocks that research the treatment of mental illnesses based on the use of one or more psychedelic substances - weekly and YTD results. 
Via Talk Markets
News headline image
Cybin, GH Research Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
This Analyst Still Has Confidence In Atai Life Sciences' Pipeline Despite Recent Setbacks ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023 ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023 ↗
 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 26, 2023 ↗
 
Via Benzinga
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
EQNX::TICKER_START (OTCQB:LOBEF),(NASDAQ:ATAI),(NASDAQ:CMPS),(NYSE:CYBN),(NASDAQ:MNMD) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Economy
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023 ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About ATAI Life Sciences ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023 ↗
 
Via Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook ↗
In our latest Trade To Black Podcast, TDR Founder Shadd Dales and lead financial writer Benjamin A. Smith interview the founder of Apeiron Investment Group, Christian Angermayer. 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 23, 2023 ↗
 
Via Benzinga
News headline image
"Rags-To-Riches" Portfolio Update: Week Ending January 20, 2023 ↗
My new portfolio of 14 cannabis, psychedelic and plant-based food stocks were cumulatively pretty awful in 2022, thus could well offer high returns in 2023. 
Via Talk Markets
News headline image
Largest Psychedelic Stocks +3% This Week; Now +15% YTD ↗
Our Psychedelic Drug Stocks Index tracks the six largest psychedelic stocks, by market capitalization, that research the treatment of mental illnesses based on the use of one or more of 10 different... 
Via Talk Markets
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023 ↗
 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More ↗
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023 ↗
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today ↗
 
Via Benzinga
News headline image
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results ↗
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From January 9, 2023 ↗
 
Via Benzinga
News headline image
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
From atai Life Sciences
Via GlobeNewswire
News headline image
My "Rags-To-Riches" Portfolio For 2023: An Introduction ↗
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up? 
Via Talk Markets
News headline image
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges ↗
Clinical-stage psychedelics biotech atai Life Sciences (NASDAQ: ATAI) shared the results of its NYC-based subsidiary NYC-based Perception Neuroscience’s Phase 2a study of proprietary R-ketamine PCN-101... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.